SCHEMBL8700685

SCHEMBL8700685

CC(COc1ccc(CC(=O)Nc2ccc(C(F)(F)F)cc2)cc1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ PSMB5 P28074 2/20 0.51
▸ RORC P51449 2/20 0.50
▸ MDH1 P40925 1/20 0.50
▸ MDH2 P40926 1/20 0.50
▸ PPARA Q07869 1/20 0.48
▸ NLRP3 Q96P20 1/20 0.48
▸ MAPT P10636 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ SLC1A3 P43003 1/20 0.47
▸ SLC1A2 P43004 1/20 0.47
▸ SLC1A1 P43005 1/20 0.47
▸ LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8412806 0.87 GAA (0.61) SMN1; SMN2RAB9ANPC1HPGDPSMB5
SCHEMBL8695260 0.86 SMN1; SMN2 (0.56) EPHX2SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL8411536 0.86 RAB9A (0.61) EPHX2SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL8411677 0.85 ADRB1 (0.57) EPHX2SMN1; SMN2RAB9ANPC1HPGD
SCHEMBL8410207 0.85 RAB9A (0.56) SMN1; SMN2RAB9ANPC1HPGDNLRP3
SCHEMBL16379339 0.84 PPARA (0.49) PSMB5PPARAALDH1A1
SCHEMBL8409841 0.80 SMN1; SMN2 (0.48) SMN1; SMN2RAB9ANPC1HPGDNLRP3
SCHEMBL1304060 0.80 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL8412730 0.79 SMN1; SMN2 (0.47) SMN1; SMN2RAB9ANPC1HPGDRORC
SCHEMBL2063998 0.78 GAA (0.69) EPHX2SMN1; SMN2RAB9ARORCMDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5731454-A Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood VIRGINIA COMMONWEALTH UNIVERSITY (US) 1998-03-24 — — US disclosed
US-5705521-A Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors THE CENTER FOR INNOVATIVE TECHNOLOGY (US) 1998-01-06 — — US disclosed
Send feedback